Clear all

Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

1,542 results found

Article
Ask Lexy

Osborne Clarke | United Kingdom | 15 Dec 2022

The UK Patents Court puts an arrow through Teva's application for declaratory relief

The Court of Appeal has upheld the decision of the High Court to reject Teva's application for Arrow declaratory relief for importing and selling…
Article
Ask Lexy

Bird & Bird LLP | Belgium, European Union, Netherlands | 9 Dec 2022

Rebranding generics as branded medicines - CJEU issues new guidance

The CJEU has provided welcome new guidance on when parallel importers can rebrand generic medicines with the original trade mark of the reference…
Commentary
Ask Lexy

Venable LLP | USA | 5 Dec 2022

Win for Novartis on motion to dismiss in pharmaceutical patent litigation case

🕑 1 minute Novartis Pharmaceuticals Corporation recently secured a victory on a motion to dismiss certain defendants' counterclaims in patent litigation concerning Novartis's Entresto drug product. Judge Richard G Andrews, of the District Court for the District of Delaware, agreed with Novartis that a defendant who files a section viii statement does not face an article III controversy of......
Article
Ask Lexy

McDermott Will & Emery | USA | 6 Oct 2022

Hold That Generic, Please: Supreme Court Grants Emergency Request to Stay Federal Circuit’s Mandate

In a rare action by the Supreme Court of the United States, Chief Justice Roberts granted Novartis’s emergency request for a stay of a mandate from…
Article
Ask Lexy

De Berti Jacchia Franchini Forlani Studio Legale | European Union | 21 Jul 2022

La Corte di Giustizia mette la parola fine alla saga Avastin/Lucentis

In data 7 luglio 2022, la Corte di Giustizia dell’Unione Europea si è Pronunciata nella Causa C-261/21, F. Hoffmann-La Roche Ltd e a. Contro Autorità…
Article
Ask Lexy

Kilpatrick Townsend & Stockton LLP | USA | 26 Jan 2022

The Sound of Silence: Claiming Negative Limitations

The specification shall contain a written description of the invention. To meet the written description requirement, the applicant must convey with…
Analysis PRO In-house
Ask Lexy

Lexology PRO | USA | 14 Apr 2021

Imposing a monitor is “very fact-dependent”, says SEC official

A senior SEC enforcement official said it’s often a challenge for government lawyers to determine whether to impose a compliance monitor on a company.
Lexology Learn videos PRO

Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021

How compliance games boost business engagement

Rafael Ferri, legal director at Novartis (Brazil), looks back at his experiments with gamification to boost compliance-business engagement while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology Learn videos PRO

Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021

How to increase business-compliance engagement

Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices to boost compliance-business engagement that he used while working as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Lexology Learn videos PRO

Lexology PRO | Australia, Brazil, Canada, etc. | 9 Feb 2021

How to facilitate business-compliance engagement during COVID-19

Rafael Ferri, legal director at Novartis (Brazil), discusses the best practices he used to boost compliance-business engagement during the COVID-19 pandemic in his role as head of legal and compliance at Sandoz, a division of Novartis Group.Interview conducted by Samantha Gilbert, content editor for Lexology PRO.
Previous page 1 2 3 ...